Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial von Arathoon, Eduardo, Bhorat, Asad, Silaghi, Rodica, Crauwels, Herta, Lavreys, Ludo, Tambuyzer, Lotke, Van Baelen, Ben, Vanveggel, Simon, Opsomer, Magda

Volltext

A week 48 randomized phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve HIV-1 patients von Eron, Joseph J, Orkin, Chloe, Gallant, Joel, Molina, Jean-Michel, Negredo, Eugenia, Antinori, Andrea, Mills, Anthony, Reynes, Jacques, Van Landuyt, Erika, Lathouwers, Erkki, Hufkens, Veerle, Jezorwski, John, Vanveggel, Simon, Opsomer, Magda

Volltext

The DIANA Study: Continued Access to Darunavir/Ritonavir (DRV/r) and Long-Term Safety Follow-Up in HIV-1-Infected Pediatric Patients Aged 3 to < 18 Years von Violari, Avy, Masenya, Maysseb, Blanche, Stephane, Vanveggel, Simon, Hufkens, Veerle, Chetty, Polan, Opsomer, Magda

Volltext

Pharmacokinetics of darunavir in fixed-dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers von Kakuda, Thomas N., Opsomer, Magda, Timmers, Maarten, Iterbeke, Koen, Van De Casteele, Tom, Hillewaert, Vera, Petrovic, Romana, Hoetelmans, Richard M. W.

Volltext

Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age von MacBrayne, Christine E., Rutstein, Richard M., Wiznia, Andrew A., Graham, Bobbie, Alvero, Carmelita G., Fairlie, Lee, Lypen, Kathryn, George, Kathleen H., Townley, Ellen, Moye, Jack, Costello, Diane G., Reding, Christina A., Barroso Hofer, Cristina, Crauwels, Herta M., Woot de Trixhe, Xavier, Tambuyzer, Lotke, Vanveggel, Simon, Opsomer, Magda, Kiser, Jennifer J.

Volltext

Bioequivalence of a darunavir/cobicistat fixed-dose combination tablet versus single agents and food effect in healthy volunteers von Kakuda, Thomas N, Van De Casteele, Tom, Petrovic, Romana, Neujens, Mark, Salih, Hiba, Opsomer, Magda, Hoetelmans, Richard Mw

Volltext

Cobicistat-boosted darunavir in HIV-1-infected adults: week 48 results of a Phase IIIb, open-label single-arm trial von Tashima, Karen, Crofoot, Gordon, Tomaka, Frank L, Kakuda, Thomas N, Brochot, Anne, Van de Casteele, Tom, Opsomer, Magda, Garner, William, Margot, Nicolas, Custodio, Joseph M, Fordyce, Marshall W, Szwarcberg, Javier

Volltext

Safety and Efficacy of Darunavir/Ritonavir in Treatment-experienced Pediatric Patients: Week 48 Results of the ARIEL Trial von Violari, Avy, Bologna, Rosa, Kumarasamy, Nagalingeswaran, Pilotto, Jose Henrique, Hendrickx, Annemie, Kakuda, Thomas N, Lathouwers, Erkki, Opsomer, Magda, Van de Casteele, Tom, Tomaka, Frank L

Volltext

Evaluation of Cardiovascular Disease Risk in HIV-1–Infected Patients Treated with Darunavir von Opsomer, Magda, Dimitrova, Dessislava, Verspeelt, Johan, Purrington, Amy, Mehbob, Abdul, Chavers, Scott, Pai, Helen, Vanveggel, Simon, Luo, Donghan, Brown, Kimberley, Moecklinghoff, Christiane, Nettles, Richard E., Boven, Katia

Volltext

Assessment of etravirine resistance in HIV-1-infected paediatric patients using population and deep sequencing: final results of the PIANO study von Tambuyzer, Lotke, Thys, Kim, Hoogstoel, Annemie, Nijs, Steven, Tomaka, Frank, Opsomer, Magda, De Meyer, Sandra, Vingerhoets, Johan

Volltext

Bioequivalence of the Once‐Daily Single‐Tablet Regimen of Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Compared to Combined Intake of the Separate Agents and the... von Crauwels, Herta M., Baugh, Bryan, Landuyt, Erika, Vanveggel, Simon, Hijzen, Anja, Opsomer, Magda

Volltext

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate... von Eron, Joseph J, Orkin, Chloe, Cunningham, Douglas, Pulido, Federico, Post, Frank A, De Wit, Stephane, Lathouwers, Erkki, Hufkens, Veerle, Jezorwski, John, Petrovic, Romana, Brown, Kimberley, Van Landuyt, Erika, Opsomer, Magda, De Wit, S, Florence, E, Moutschen, M, Van Wijngaerden, E, Vandekerckhove, L, Vandercam, B, Brunetta, J, Conway, B, Klein, M, Murphy, D, Rachlis, A, Shafran, S, Walmsley, S, Ajana, F, Cotte, L, Girardy, P.-M, Katlama, C, Molina, J.-M, Poizot-Martin, I, Raffi, F, Rey, D, Reynes, J, Teicher, E, Yazdanpanah, Y, Gasiorowski, J, Halota, W, Horban, A, Piekarska, A, Witor, A, Arribas, J.R, Perez-Valero, I, Berenguer, J, Casado, J, Gatell, J.M, Gutierrez, F, Galindo, M.J, Gutierrez, M.D.M, Iribarren, J.A, Knobel, H, Negredo, E, Pineda, J.A, Podzamczer, D, Portilla Sogorb, J, Pulido, F, Ricart, C, Rivero, A, Santos Gil, I, Blaxhult, A, Flamholc, L, Gisslen, M, Thalme, A, Fehr, J, Rauch, A, Stoeckle, M, Clarke, A, Gazzard, B.G, Johnson, M.A, Orkin, C, Post, F, Ustianowski, A, Waters, L, Bailey, J, Benson, P, Bhatti, L, Brar, I, Bredeek, U.F, Brinson, C, Crofoot, G, Cunningham, D, DeJesus, E, Dietz, C, Dretler, R, Eron, J, Felizarta, F, Fichtenbaum, C, Gallant, J, Gathe, J, Hagins, D, Henn, S, Henry, W.K, Huhn, G, Jain, M, Lucasti, C, Martorell, C, McDonald, C, Mills, A, Morales-Ramirez, J

Volltext

Correction to: Evaluation of Cardiovascular Disease Risk in HIV‑1–Infected Patients Treated with Darunavir von Opsomer, Magda, Dimitrova, Dessislava, Verspeelt, Johan, Purrington, Amy, Mehbob, Abdul, Chavers, Scott, Pai, Helen, Vanveggel, Simon, Luo, Donghan, Brown, Kimberley, Moecklinghoff, Christiane, Nettles, Richard E., Boven, Katia

Volltext

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase... von Lathouwers, Erkki, Wong, Eric Y, Brown, Kimberley, Baugh, Bryan, Ghys, Anne, Jezorwski, John, Mohsine, El Ghazi, Van Landuyt, Erika, Opsomer, Magda, De Meyer, Sandra, De Wit, S, Florence, E, Vandekerckhove, L, Vandercam, B, Brunetta, J, Klein, M, Murphy, D, Rachlis, A, Walmsley, S, Ajana, F, Cotte, L, Girard, P.-M, Katlama, C, Molina, J.-M, Poizot-Martin, I, Raffi, F, Rey, D, Reynes, J, Teicher, E, Yazdanpanah, Y, Arasteh, K, Bickel, M, Bogner, J, Esser, S, Faetkenheuer, G, Jessen, H, Kern, W, Rockstroh, J, Spinner, C, Stellbrink, H.-J, Stoehr, A, Antinori, A, Castelli, F, Chirianni, A, De Luca, A, Di Biagio, A, Galli, M, Lazzarin, A, Maggiolo, F, Maserati, R, Mussini, C, Garlicki, A, Gasiorowski, J, Halota, W, Horban, A, Parczewski, M, Piekarska, A, Belonosova, E, Chernova, O, Dushkina, N, Kulagin, V, Ryamova, E, Shuldyakov, A, Sizova, N, Tsybakova, O, Voronin, E, Yakovlev, A, Antela, A, Arribas, J.R, Berenguer, J, Casado, J, Estrada, V, Galindo, M.J, Garcia Del Toro, M, Gatell, J.M, Gorgolas, M, Gutierrez, F, Gutierrez, M.D.M, Negredo, E, Pineda, J.A, Podzamczer, D, Portilla Sogorb, J, Rivero, A, Rubio, R, Viciana, P, De Los Santos, I, Clarke, A, Gazzard, B.G, Johnson, M.A, Orkin, C, Reeves, I, Waters, L, Benson, P, Bhatti, L, Bredeek, F, Crofoot, G, Cunningham, D, DeJesus, E, Eron, J, Felizarta, F

Volltext

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate... von Eron, Joseph J, Orkin, Chloe, Cunningham, Douglas, Pulido, Federico, Post, Frank A, De Wit, Stéphane, Lathouwers, Erkki, Hufkens, Veerle, Jezorwski, John, Petrovic, Romana, Brown, Kimberley, Van Landuyt, Erika, De Wit, S, Florence, E, Moutschen, M, Van Wijngaerden, E, Vandekerckhove, Linos, Vandercam, B, Conway, B, Klein, M, Murphy, D, Rachlis, A, Shafran, S, Walmsley, S, Ajana, F, Cotte, L, Girardy, P-M, Katlama, C, Molina, J-M, Rey, D, Reynes, J, Teicher, E, Yazdanpanah, Y, Gasiorowski, J, Halota, W, Horban, A, Piekarska, A, Witor, A, Arribas, JR, Casado, J, Gatell, JM, Gutierrez, F, Gutierrez, MDM, Iribarren, JA, Knobel, H, Negredo, E, Pineda, JA, Podzamczer, D, Portilla Sogorb, J, Pulido, F, Ricart, C, Rivero, A, Santos Gil, I, Blaxhult, A, Flamholc, L, Fehr, J, Rauch, A, Clarke, A, Gazzard, BG, Johnson, MA, Orkin, C, Post, F, Ustianowski, A, Waters, L, Bailey, J, Benson, P, Brar, I, Bredeek, UF, Brinson, C, Crofoot, G, Cunningham, D, DeJesus, E, Dietz, C, Dretler, R, Eron, J, Fichtenbaum, C, Gallant, J, Gathe, J, Hagins, D, Henn, S, Huhn, G, Jain, M, Lucasti, C, Martorell, C, McDonald, C, Mills, A, Mounzer, K, Olivet, H, Osiyemi, O, Prelutsky, D, Ramgopal, M, Richmond, G, Ruane, P, Scarsella, A, Shalit, P, Shamblaw, D, Voskuhl, G, Ward, D, Wilkin, A, de Vente, J

Volltext

Week 48 results of a Phase IV trial of etravirine with antiretrovirals other than darunavir/ritonavir in HIV‐1‐infected treatment‐experienced adults von Arathoon, Eduardo, Bhorat, Asad, Silaghi, Rodica, Crauwels, Herta, Lavreys, Ludo, Tambuyzer, Lotke, Vanveggel, Simon, Opsomer, Magda

Volltext

Anti-IL6 Agent for Treating Coronavirus Infection von Opsomer, Magda, Boven, Katia, Woodfall, Brian, Chien, Jason

Volltext bestellen

Compositions comprising darunavir, cobicistat, emtricitabine and tenofovir alafenamide for use in the treatment of HIV von KAUWENBERGHS, Greet, DE SMEDT, Goedele, ZIA, Vahid, NETTLES, Richard, OPSOMER, Magda, HENRIST, Dominiek, BOVEN, Katia, MCCALLISTER, Scott, DRIESEN, Regina, MERTENS, Roel, MATHUR, Sandeep, PRYZ, William

Volltext bestellen

Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients von Orkin, Chloe, Eron, Joseph J, Rockstroh, Jürgen Kurt, Podzamczer Palter, Daniel, Esser, Stefan, Vandekerckhove, Linos, Van Landuyt, Erika, Lathouwers, Erkki, Hufkens, Veerle, Jezorwski, John, Opsomer, Magda, AMBER study group

Volltext bestellen

Compositions and methods of treating HIV von Opsomer, Magda, Boven, Katia, Driesen, Regina, Pyrz, William, Henrist, Dominiek, Zia, Vahid, Kauwenberghs, Greet, Mertens, Roel, De Smedt, Goedele, McCallister, Scott, Mathur, Sandeep, Nettles, Richard

Volltext bestellen